{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T17:55:01Z","timestamp":1795024501167,"version":"4.10.2"},"reference-count":79,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:p>Adenoviruses result in a wide array of clinical presentations, including primarily respiratory, gastrointestinal, genitourinary, or systemic infections. Although adenovirus causes mild disease limited to a single organ system in immunocompetent individuals, severe and life-threatening infections do rarely occur. Disseminated disease and severe localized disease resulting in significant morbidity and mortality have been well described in the immunocompromised populations. Although asymptomatic viremia, respiratory tract, and gastrointestinal infections are the most common disease in most transplant patients, renal transplant patients more commonly experience urinary tract infections, including hemorrhagic cystitis or nephritis. Diagnosis requires astute clinical awareness of the patient\u2019s clinical presentation that would be compatible with adenovirus combined with cultures, molecular testing, polymerase chain reaction, and tissue sampling. There is no Food and Drug Administration\u2013approved treatment for adenovirus; however, several studies have evaluated therapeutic options including cidofovir, brincidofovir, and immunotherapy. This article will summarize our current understanding of adenovirus in the transplant population.<\/jats:p>","DOI":"10.1097\/tp.0000000000003988","type":"journal-article","created":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T23:01:43Z","timestamp":1638486103000},"page":"920-927","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":74,"title":["Adenovirus Infection and Transplantation"],"prefix":"10.1097","volume":"106","author":[{"given":"Omar M.","family":"Al-Heeti","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, IL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen P.","family":"Cathro","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Virginia School of Medicine, Charlottesville, VA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Ison","sequence":"additional","affiliation":[{"name":"Divisions of Infectious Diseases and Organ Transplantation, Transplant and Immunocompromised Host Infectious Diseases Service, Northwestern University Feinberg School of Medicine, Chicago, IL."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,11,24]]},"reference":[{"key":"R2-20250604","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1128\/CMR.00116-13","article-title":"Adenovirus infections in immunocompetent and immunocompromised patients.","volume":"27","author":"Lion","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"R3-20250604","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/sj.bmt.1702716","article-title":"Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation.","volume":"26","author":"Baldwin","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"R4-20250604","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.DMIH2-0020-2015","article-title":"Adenovirus.","volume":"4","author":"Ison","year":"2016","journal-title":"Microbiol Spectr"},{"key":"R5-20250604","first-page":"5981289","article-title":"Successful treatment of adenovirus infection with brincidofovir in an immunocompromised patient after hematological stem cell transplantation.","volume":"2020","author":"Van Genechten","year":"2020","journal-title":"Case Rep Infect Dis"},{"key":"R7-20250604","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1002\/1873-3468.13576","article-title":"Adenovirus persistence, reactivation, and clinical management.","volume":"593","author":"Lion","year":"2019","journal-title":"FEBS Lett"},{"key":"R8-20250604","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1055\/s-0036-1584923","article-title":"Adenovirus: epidemiology, global spread of novel serotypes, and advances in treatment and prevention.","volume":"37","author":"Lynch","year":"2016","journal-title":"Semin Respir Crit Care Med"},{"key":"R9-20250604","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/QCO.0000000000000605","article-title":"Adenovirus infection and disease in recipients of hematopoietic cell transplantation.","volume":"32","author":"Dailey Garnes","year":"2019","journal-title":"Curr Opin Infect Dis"},{"key":"R10-20250604","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1182\/blood-2002-02-0377","article-title":"Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery.","volume":"100","author":"Chakrabarti","year":"2002","journal-title":"Blood"},{"key":"R11-20250604","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/infdis\/169.4.775","article-title":"Increasing incidence of adenovirus disease in bone marrow transplant recipients.","volume":"169","author":"Flomenberg","year":"1994","journal-title":"J Infect Dis"},{"key":"R12-20250604","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1086\/505498","article-title":"Adenovirus infections in transplant recipients.","volume":"43","author":"Ison","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R13-20250604","doi-asserted-by":"crossref","first-page":"e13527","DOI":"10.1111\/ctr.13527","article-title":"Adenovirus in solid organ transplant recipients: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.","volume":"33","author":"Florescu","year":"2019","journal-title":"Clin Transplant"},{"key":"R14-20250604","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S1083-8791(03)00102-2","article-title":"Adenovirus infection in hematopoietic stem cell transplantation: effect of ganciclovir and impact on survival.","volume":"9","author":"Bruno","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"R15-20250604","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1080\/10428190310001628176","article-title":"Adenovirus infections in stem cell transplant recipients: recent developments in understanding of pathogenesis, diagnosis and management.","volume":"45","author":"Suparno","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"R16-20250604","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1056\/NEJM198502283120901","article-title":"Adenovirus infections in patients undergoing bone-marrow transplantation.","volume":"312","author":"Shields","year":"1985","journal-title":"N Engl J Med"},{"key":"R17-20250604","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1093\/ndt\/gft036","article-title":"What do we know about adenovirus in renal transplantation?","volume":"28","author":"Florescu","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"R18-20250604","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.semnephrol.2016.05.018","article-title":"Respiratory viruses: influenza, RSV, and adenovirus in kidney transplantation.","volume":"36","author":"Hawkinson","year":"2016","journal-title":"Semin Nephrol"},{"key":"R19-20250604","doi-asserted-by":"crossref","DOI":"10.1111\/tid.12716","article-title":"Adenoviral nephritis in a renal transplant recipient: case report and literature review.","volume":"19","author":"Veer","year":"2017","journal-title":"Transpl Infect Dis"},{"key":"R20-20250604","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1111\/j.1600-6143.2005.01033.x","article-title":"A surveillance study of adenovirus infection in adult solid organ transplant recipients.","volume":"5","author":"Humar","year":"2005","journal-title":"Am J Transplant"},{"key":"R21-20250604","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.healun.2006.09.015","article-title":"Assessment of adenovirus infection in adult lung transplant recipients using molecular surveillance.","volume":"25","author":"Humar","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"R22-20250604","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1016\/j.transproceed.2004.10.090","article-title":"Hemorrhagic adenovirus cystitis after renal transplantation.","volume":"36","author":"Hofland","year":"2004","journal-title":"Transplant Proc"},{"key":"R23-20250604","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/tid.12022","article-title":"European guidelines for diagnosis and treatment of adenovirus infection in leukemia and stem cell transplantation: summary of ECIL-4 (2011).","volume":"14","author":"Matthes-Martin","year":"2012","journal-title":"Transpl Infect Dis"},{"key":"R24-20250604","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1086\/521851","article-title":"Quantitative real-time polymerase chain reaction for detection of adenovirus after T cell-replete hematopoietic cell transplantation: viral load as a marker for invasive disease.","volume":"45","author":"Erard","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R25-20250604","doi-asserted-by":"crossref","first-page":"e1980","DOI":"10.1002\/rmv.1980","article-title":"Management of adenovirus infection in patients after haematopoietic stem cell transplantation: state-of-the-art and real-life current approach: a position statement on behalf of the Infectious Diseases Working Party of the European Society of Blood and Marrow Transplantation.","volume":"28","author":"Hiwarkar","year":"2018","journal-title":"Rev Med Virol"},{"key":"R26-20250604","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1471-2334-14-50","article-title":"Molecular identification of adenoviruses associated with respiratory infection in Egypt from 2003 to 2010.","volume":"14","author":"Demian","year":"2014","journal-title":"BMC Infect Dis"},{"key":"R27-20250604","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/infdis\/jiv141","article-title":"Molecular epidemiology of adenovirus type 21 respiratory strains isolated from US military trainees (1996-2014).","volume":"212","author":"Kajon","year":"2015","journal-title":"J Infect Dis"},{"key":"R28-20250604","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1128\/JCM.03297-12","article-title":"Quantitative real-time PCR assay panel for detection and type-specific identification of epidemic respiratory human adenoviruses.","volume":"51","author":"Lu","year":"2013","journal-title":"J Clin Microbiol"},{"key":"R30-20250604","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1432-2277.2009.00838.x","article-title":"Adenoviral graft-nephritis: case report and review of the literature.","volume":"22","author":"Hensley","year":"2009","journal-title":"Transpl Int"},{"key":"R31-20250604","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1128\/JCM.03368-12","article-title":"Comparison of the Biofire FilmArray RP, Genmark eSensor RVP, Luminex xTAG RVPv1, and Luminex xTAG RVP fast multiplex assays for detection of respiratory viruses.","volume":"51","author":"Popowitch","year":"2013","journal-title":"J Clin Microbiol"},{"key":"R32-20250604","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1177\/135965350901400110","article-title":"Differential susceptibility of adenovirus clinical isolates to cidofovir and ribavirin is not related to species alone.","volume":"14","author":"Morfin","year":"2009","journal-title":"Antivir Ther"},{"key":"R33-20250604","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/135965350501000204","article-title":"In vitro susceptibility of adenovirus to antiviral drugs is species-dependent.","volume":"10","author":"Morfin","year":"2005","journal-title":"Antivir Ther"},{"key":"R34-20250604","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/bmt.2011.227","article-title":"Successful treatment with plasma exchange for disseminated cidofovir-resistant adenovirus disease in a pediatric SCT recipient.","volume":"47","author":"Nishikawa","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"R35-20250604","first-page":"1812","article-title":"The antiviral resistance and replication of cidofovir-resistant adenovirus variants in the New Zealand White rabbit ocular model.","volume":"42","author":"Romanowski","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R36-20250604","doi-asserted-by":"crossref","first-page":"5476","DOI":"10.1182\/blood-2010-04-259291","article-title":"How I treat adenovirus in hematopoietic stem cell transplant recipients.","volume":"116","author":"Lindemans","year":"2010","journal-title":"Blood"},{"key":"R37-20250604","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1399-3062.2009.00391.x","article-title":"Safety and tolerability of cidofovir in high-risk pediatric patients.","volume":"11","author":"Bhadri","year":"2009","journal-title":"Transpl Infect Dis"},{"key":"R38-20250604","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.3324\/haematol.11279","article-title":"Disseminated adenovirus infections after allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcome.","volume":"92","author":"Robin","year":"2007","journal-title":"Haematologica"},{"key":"R39-20250604","doi-asserted-by":"crossref","first-page":"e13231","DOI":"10.1111\/petr.13231","article-title":"Virologic response with 2 different cidofovir dosing regimens for preemptive treatment of adenovirus DNAemia in pediatric solid organ transplant recipients.","volume":"22","author":"Guerra Sanchez","year":"2018","journal-title":"Pediatr Transplant"},{"key":"R40-20250604","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1086\/380450","article-title":"Real-time blood plasma polymerase chain reaction for management of disseminated adenovirus infection.","volume":"38","author":"Leruez-Ville","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R41-20250604","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1399-3046.2008.01014.x","article-title":"Adenovirus infection and treatment with cidofovir in children after liver transplantation.","volume":"13","author":"Engelmann","year":"2009","journal-title":"Pediatr Transplant"},{"key":"R42-20250604","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1399-3046.2005.00411.x","article-title":"Disseminated adenovirus infection with respiratory failure in pediatric liver transplant recipients: impact of intravenous cidofovir and inhaled nitric oxide.","volume":"10","author":"Wallot","year":"2006","journal-title":"Pediatr Transplant"},{"key":"R43-20250604","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1097\/00007890-200210150-00027","article-title":"Intravenous Cidofovir therapy for disseminated adenovirus in a pediatric liver transplant recipient.","volume":"74","author":"Carter","year":"2002","journal-title":"Transplantation"},{"key":"R44-20250604","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.healun.2007.06.009","article-title":"Treatment of adenovirus pneumonia with cidofovir in pediatric lung transplant recipients.","volume":"26","author":"Doan","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"R45-20250604","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1111\/j.1600-6143.2004.00631.x","article-title":"Monitoring of adenovirus infection in pediatric transplant recipients by quantitative PCR: report of six cases and review of the literature.","volume":"4","author":"Seidemann","year":"2004","journal-title":"Am J Transplant"},{"key":"R46-20250604","doi-asserted-by":"crossref","first-page":"758","DOI":"10.12688\/f1000research.8374.2","article-title":"Use of cidofovir in pediatric patients with adenovirus infection.","volume":"5","author":"Ganapathi","year":"2016","journal-title":"F1000Res"},{"key":"R47-20250604","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1399-3062.2009.00452.x","article-title":"Disseminated adenovirus infection in renal transplant recipients: the role of cidofovir and intravenous immunoglobulin.","volume":"12","author":"Saquib","year":"2010","journal-title":"Transpl Infect Dis"},{"key":"R48-20250604","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/TP.0b013e3181e0de97","article-title":"Adenovirus infections in pediatric small bowel transplant recipients.","volume":"90","author":"Florescu","year":"2010","journal-title":"Transplantation"},{"key":"R49-20250604","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/01.TP.0000072808.93060.0F","article-title":"Adenovirus infection in pediatric small bowel transplantation recipients.","volume":"76","author":"Pinchoff","year":"2003","journal-title":"Transplantation"},{"key":"R50-20250604","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.healun.2008.03.001","article-title":"Successful cidofovir treatment in an adult heart transplant recipient with severe adenovirus pneumonia.","volume":"27","author":"Refaat","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"R51-20250604","doi-asserted-by":"crossref","first-page":"A15","DOI":"10.1053\/j.ajkd.2018.06.009","article-title":"Fever and gross hematuria in kidney transplant recipient.","volume":"72","author":"Pochineni","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"R52-20250604","first-page":"231","article-title":"Disseminated adenovirus infection in heart and kidney transplant.","volume":"46","author":"Xu","year":"2018","journal-title":"Turk Kardiyol Dern Ars"},{"key":"R53-20250604","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.idcr.2018.01.011","article-title":"Adenovirus, herpes simplex virus and cytomegalovirus infection in a lung transplant recipient.","volume":"11","author":"Nagarakanti","year":"2018","journal-title":"Idcases"},{"key":"R54-20250604","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/tid.12248","article-title":"Adenovirus causing fever, upper respiratory infection, and allograft nephritis complicated by persistent asymptomatic viremia.","volume":"16","author":"Lachiewicz","year":"2014","journal-title":"Transpl Infect Dis"},{"issue":"suppl 1","key":"R55-20250604","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/nep.12192","article-title":"Disseminated adenovirus infection in kidney transplant recipient.","volume":"19","author":"Dawood","year":"2014","journal-title":"Nephrology (Carlton)"},{"key":"R56-20250604","first-page":"969186","article-title":"Severe necrotizing adenovirus tubulointerstitial nephritis in a kidney transplant recipient.","volume":"2013","author":"Parasuraman","year":"2013","journal-title":"Case Rep Transplant"},{"key":"R57-20250604","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1399-3062.2010.00577.x","article-title":"Acute kidney injury requiring dialysis secondary to adenovirus nephritis in renal transplant recipient.","volume":"13","author":"Sujeet","year":"2011","journal-title":"Transpl Infect Dis"},{"key":"R58-20250604","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/j.1600-6143.2011.03479.x","article-title":"Adenovirus disease after kidney transplantation: course of infection and outcome in relation to blood viral load and immune recovery.","volume":"11","author":"Watcharananan","year":"2011","journal-title":"Am J Transplant"},{"key":"R59-20250604","first-page":"250","article-title":"Life-threatening adenovirus infection in a kidney transplant recipient.","volume":"2","author":"Barraclough","year":"2009","journal-title":"NDT Plus"},{"key":"R60-20250604","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/tid.12342","article-title":"Disseminated adenovirus disease in heart transplant recipient presenting with conjunctivitis.","volume":"17","author":"Bruminhent","year":"2015","journal-title":"Transpl Infect Dis"},{"key":"R61-20250604","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1399-3046.2007.00736.x","article-title":"Adenovirus-associated hemorrhagic cystitis in a pediatric renal transplant recipient.","volume":"11","author":"Keswani","year":"2007","journal-title":"Pediatr Transplant"},{"key":"R62-20250604","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/ndt\/gfl843","article-title":"Late-onset acute haemorrhagic necrotizing granulomatous adenovirus tubulointerstitial nephritis in a renal allograft.","volume":"22","author":"Alsaad","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"R63-20250604","first-page":"488","article-title":"Late presentation of adenovirus-induced hemorrhagic cystitis and ureteral obstruction in a kidney-pancreas transplant recipient.","volume":"28","author":"Klein","year":"2015","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"R64-20250604","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.transproceed.2012.06.059","article-title":"Histopathologic resolution of adult liver transplantation adenovirus hepatitis with cidofovir and intravenous immunoglobulin: a case report.","volume":"45","author":"Kerensky","year":"2013","journal-title":"Transplant Proc"},{"key":"R65-20250604","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/qjmed\/hcr117","article-title":"Acute liver failure secondary to opportunistic viral infection in adult solid organ transplant recipients.","volume":"105","author":"Claridge","year":"2012","journal-title":"QJM"},{"key":"R66-20250604","doi-asserted-by":"crossref","first-page":"ofy354","DOI":"10.1093\/ofid\/ofy354","article-title":"Probable donor-derived human adenovirus type 34 infection in 2 kidney transplant recipients from the same donor.","volume":"6","author":"Pettengill","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"R67-20250604","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.bbmt.2011.09.007","article-title":"Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients.","volume":"18","author":"Florescu","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"R68-20250604","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.antiviral.2014.10.005","article-title":"Cidofovir and brincidofovir reduce the pathology caused by systemic infection with human type 5 adenovirus in immunosuppressed Syrian hamsters, while ribavirin is largely ineffective in this model.","volume":"112","author":"Tollefson","year":"2014","journal-title":"Antiviral Res"},{"key":"R69-20250604","doi-asserted-by":"crossref","first-page":"7293","DOI":"10.1073\/pnas.0800200105","article-title":"Hexadecyloxypropyl-cidofovir, CMX001, prevents adenovirus-induced mortality in a permissive, immunosuppressed animal model.","volume":"105","author":"Toth","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R70-20250604","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1586\/14787210.2014.948847","article-title":"Development of CMX001 (Brincidofovir) for the treatment of serious diseases or conditions caused by dsDNA viruses.","volume":"12","author":"Florescu","year":"2014","journal-title":"Expert Rev Anti Infect Ther"},{"key":"R71-20250604","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMoa1303688","article-title":"CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation.","volume":"369","author":"Marty","year":"2013","journal-title":"N Engl J Med"},{"key":"R72-20250604","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s15010-020-01484-7","article-title":"Adenovirus diseases: a systematic review and meta-analysis of 228 case reports.","volume":"49","author":"Gu","year":"2021","journal-title":"Infection"},{"key":"R73-20250604","doi-asserted-by":"crossref","first-page":"e13769","DOI":"10.1111\/petr.13769","article-title":"Brincidofovir for the treatment of human adenovirus infection in pediatric solid organ transplant recipients: a case series.","volume":"24","author":"Londeree","year":"2020","journal-title":"Pediatr Transplant"},{"key":"R74-20250604","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jcv.2010.10.016","article-title":"Eradication of disseminated adenovirus infection in a pediatric hematopoietic stem cell transplantation recipient using the novel antiviral agent CMX001.","volume":"50","author":"Paolino","year":"2011","journal-title":"J Clin Virol"},{"key":"R75-20250604","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jcv.2017.09.013","article-title":"Disseminated adenovirus infection after allogeneic stem cell transplant and the potential role of brincidofovir\u2014case series and 10 year experience of management in an adult transplant cohort.","volume":"96","author":"Ramsay","year":"2017","journal-title":"J Clin Virol"},{"key":"R76-20250604","first-page":"e5296","article-title":"Brincidofovir (CMX001) for the treatment of severe adenoviral pneumonia in kidney transplant recipient.","volume":"11","author":"Sudhindra","year":"2019","journal-title":"Cureus"},{"key":"R77-20250604","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.bbmt.2018.09.038","article-title":"A randomized, double-blind, placebo-controlled phase 3 trial of oral brincidofovir for cytomegalovirus prophylaxis in allogeneic hematopoietic cell transplantation.","volume":"25","author":"Marty","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"R78-20250604","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.bbmt.2016.12.621","article-title":"Brincidofovir for asymptomatic adenovirus viremia in pediatric and adult allogeneic hematopoietic cell transplant recipients: a randomized placebo-controlled phase II trial.","volume":"23","author":"Grimley","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"R79-20250604","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1086\/420817","article-title":"Effect of ribavirin on the plasma viral DNA load in patients with disseminating adenovirus infection.","volume":"38","author":"Lankester","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R80-20250604","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13045-019-0701-1","article-title":"Strategies of adoptive T-cell transfer to treat refractory viral infections post allogeneic stem cell transplantation.","volume":"12","author":"Kaeuferle","year":"2019","journal-title":"J Hematol Oncol"},{"key":"R81-20250604","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1182\/blood-2013-02-486324","article-title":"Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation.","volume":"121","author":"Leen","year":"2013","journal-title":"Blood"},{"key":"R82-20250604","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.bbmt.2013.07.015","article-title":"CMV-, EBV- and ADV-specific T cell immunity: screening and monitoring of potential third-party donors to improve post-transplantation outcome.","volume":"19","author":"Sukdolak","year":"2013","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003988","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T19:08:55Z","timestamp":1749064135000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,24]]},"references-count":79,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000003988","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11,24]]}}}